Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LAWRENCE, MA--(Marketwired - Oct 13, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) - Today Boston Therapeutics and Advance Pharmaceutical Co., Ltd., which holds a license for the...
-
LAWRENCE, MA--(Marketwired - Oct 6, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong presented today the positive topline data...
-
LAWRENCE, MA--(Marketwired - Oct 3, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or the "Company") announced that it closed a private placement yielding gross proceeds to...
-
NEWTON, MA--(Marketwired - Dec 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) released final trial results from its proof of concept (POC) Sydney University study that showed consumption of...
-
NEWTON, MA--(Marketwired - Nov 20, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of metabolic...
-
MANCHESTER, NH--(Marketwired - Oct 6, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), completed enrollment...
-
MANCHESTER, NH--(Marketwired - Sep 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) (the "Company") announced that on September 24, 2015, the Company paid in-full all of the Company's...
-
MANCHESTER, NH--(Marketwired - Sep 15, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), is conducting a...
-
MANCHESTER, NH--(Marketwired - Aug 13, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of diabetes...
-
MANCHESTER, NH--(Marketwired - Aug 6, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes...